$NOVN NOVEN PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in NOVEN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NOVEN PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in NOVEN PHARMACEUTICALS INC for free.
CIK Number: 0000815838
IRS Number: 592767632
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NOVN
Company Address: 11960 SW 144TH STREET MIAMI 33185
Market Capitalization: $65.66M
Prev close: $4.07
Average Daily Volume: 284,819
Days Low: $4.06
Year Low: $3.52
Year High: $30.90
NOVEN PHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Venditti Anthony | VP - Marketing and ... | Option Exercise | D | 11.09 | 39,037 | 432,920 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Venditti Anthony | VP - Marketing and ... | Option Exercise | D | 10.69 | 79,139 | 845,996 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Option Exercise | D | 11.09 | 66,921 | 742,154 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Option Exercise | D | 13.93 | 62,500 | 870,625 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Lippman Joel | VP and Chief Medica ... | Option Exercise | D | 11.09 | 33,460 | 371,071 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Lippman Joel | VP and Chief Medica ... | Option Exercise | D | 10.86 | 78,520 | 852,727 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | DINH STEVEN M | VP & Chief Scientif ... | Option Exercise | D | 11.09 | 39,037 | 432,920 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | DINH STEVEN M | VP & Chief Scientif ... | Option Exercise | D | 11.84 | 53,107 | 628,787 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Gilbert Richard P. | Vice President - Op ... | Option Exercise | D | 11.09 | 66,921 | 742,154 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Gilbert Richard P. | Vice President - Op ... | Option Exercise | D | 14.54 | 29,806 | 433,379 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Gilbert Richard P. | Vice President - Op ... | Option Exercise | D | 22.83 | 19,908 | 454,500 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Gilbert Richard P. | Vice President - Op ... | Option Exercise | D | 13.68 | 23,191 | 317,253 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | Gilbert Richard P. | Vice President - Op ... | Option Exercise | D | 16.35 | 30,000 | 490,500 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 11.09 | 71,701 | 795,164 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive Vice Pres ... | Option Exercise | D | 14.54 | 52,161 | 758,421 | 0 |